Skip to main content
UniHealth

Doctor search

Lisa Li Zhu, MD

Rheumatology · Encino

NPI 1235524596

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
8

Offices

8 locations · The Regents of the University of California · 1,426 clinicians in this group

Looking this up.

Hospitals listed: Ronald Reagan UCLA Medical Center. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Zhu’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence A143695 · Current

Licensed to practise in California · since 2016 · expires 2027-12-31 · David Geffen School of Medicine at UCLA.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Ronald Reagan UCLA Medical CenterLos Angeles, CAAcute Care Hospital · Government - State · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of Jonsson Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 79% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 6.27 (4.69 to 7.85) · 3,570 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative respiratory failure rate: 5.17 (1.78 to 8.56) · 1,778 cases, Jul 2022 – Jun 2024Better than the national rate — Pressure ulcer rate: 0.21 (0 to 0.62) · 8,165 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.59, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.611, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.503, Oct 2024 – Sep 2025
See every measure and the patient survey for Ronald Reagan UCLA Medical Center

Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Ronald Reagan UCLA Medical Center
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths6.27 (4.69 to 7.85) · 3,570 casesWorseJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths5.17 (1.78 to 8.56) · 1,778 casesBetterJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.21 (0 to 0.62) · 8,165 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.59BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.611BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.503BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.67 (0 to 1.44) · 2,883 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.9 (0.7 to 1.09)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths171.14 (139.88 to 202.41) · 282 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.1 · 122 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.2 · 49 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.5 · 107 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths7.9 · 350 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths11.1 · 436 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths12.8 · 242 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.4 · 3,004 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.34) · 9,102 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.27 (0.09 to 0.44) · 10,460 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.67 (0.57 to 2.77) · 1,972 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.27 to 3.44) · 3,000 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.93 (3.76 to 8.09) · 2,101 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.65 (1.31 to 3.98) · 1,032 casesNo differentJul 2022 – Jun 2024
MRSA BacteremiaInfections0.56No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.626No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.8 · 138 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.9 · 357 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-7.1 · 122 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-12.9 · 385 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits13.6 · 427 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits17.1 · 404 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits4.9 (3.7 to 6.5) · 609 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.3 (10.1 to 15) · 609 casesNo differentJan 2024 – Dec 2024
Rate of readmission for CABGUnplanned return visits10.8 · 119 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.8 · 49 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits10.8 (8.5 to 13.7) · 2,701 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.8 to 1.1) · 1,463 casesNo differentJan 2024 – Dec 2024

What patients said (814 patients answered, 18% of those asked)

Patient survey stars by topic at Ronald Reagan UCLA Medical Center
Cleanliness3
Nurse communication3
Doctor communication3
Communication about medicines3
Discharge information3
Overall hospital rating4
Quietness2
Recommend hospital4
Share of patients giving the best answer at Ronald Reagan UCLA Medical Center
Room was "always" clean72%
Nurses "always" communicated well77%
Doctors "always" communicated well78%
Staff "always" explained60%
Yes, staff "did" give patients this information86%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand73%
Doctors "always" listened carefully76%
Doctors "always" treated them with courtesy and respect85%
Patients who gave a rating of "9" or "10" (high)75%
Staff "always" explained new medications74%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night43%
"YES", patients would definitely recommend the hospital79%
Staff "always" explained possible side effects45%
Yes, staff "did" give patients information about possible symptoms87%

Original Medicare doctor bills

$154,584

Medicare paid this office $154,584 for 257 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Injection, denosumab, 1 mg19$42,355None
Return visit (30+ min)180$34,301$100
New patient visit (45+ min)60$7,822$130
Long return visit (40+ min)27$4,299$143
New patient visit (60+ min)21$3,766$179
See all 10 services
Every Original Medicare service billed
Injection, denosumab, 1 mg19$42,355None
Return visit (30+ min)180$34,301$100
New patient visit (45+ min)60$7,822$130
Long return visit (40+ min)27$4,299$143
New patient visit (60+ min)21$3,766$179
Short return visit (20+ min)39$3,264$71
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's117$2,820$13
Aspiration and/or injection of fluid from large joint18$1,552$62
Injection of drug or substance under skin or into muscle24$655$11
Injection, methylprednisolone acetate, 1 mg21$119None

Who their Medicare patients are

257 Original Medicare patients in 2024. Average age 71 · Under 65 13% · 85 and older 7% · Women 73% · Also on Medicaid 27% · Health risk score 1.51. Above the middle of the specialty; the typical rheumatology clinician is at 1.38.

Conditions among them: High blood pressure 66% · Depression 33% · Diabetes 31% · Coronary heart disease 31% · Chronic kidney disease 20% · COPD 20% · Cancer 19% · Heart failure 15% · Atrial fibrillation 12% · Stroke 11% · Dementia 7%.

The office billed $1,039,596, Medicare allowed $199,475 and paid $154,584; for 9,645 services of 28 kinds; $91,728 of it was for drugs given in the office and $62,856 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20242579,645711.51$1,039,596$154,584
20231542,317731.54$418,969$60,029
20222361,557721.37$573,073$78,980
2021117566721.42$240,818$33,221
20202662721.49$29,894$5,651

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 8 services

Original Medicare services billed in 2023
Injection, denosumab, 1 mg12$20,122None
Return visit (30+ min)96$16,813$101
New patient visit (45+ min)42$5,351$127
Long return visit (40+ min)18$3,218$140
Short return visit (20+ min)17$1,547$74
Aspiration and/or injection of fluid from large joint14$1,528$57
Injection of drug or substance under skin or into muscle14$293$12
Injection, methylprednisolone acetate, 40 mg18$184None

2022: 7 services

Original Medicare services billed in 2022
Return visit (30+ min)119$24,158$103
New patient visit (45+ min)108$13,952$129
Aspiration and/or injection of fluid from large joint33$4,698$57
Long return visit (40+ min)28$4,415$152
Short return visit (20+ min)26$2,437$70
Return visit (30+ min)12$928$71
Injection, methylprednisolone acetate, 40 mg25$170None

2021: 5 services

Original Medicare services billed in 2021
Return visit (30+ min)44$10,430$109
New patient visit (45+ min)57$7,787$137
Long return visit (40+ min)20$3,196$152
New patient visit (60+ min)12$2,014$168
Aspiration and/or injection of fluid from large joint12$1,472$51

2020: 2 services

Original Medicare services billed in 2020
Return visit (30+ min)12$2,131$97
New patient visit (45+ min)13$1,889$145

Drugs they prescribed that Part D paid

$911,967

Pharmacies billed $911,967 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 3% of their Part D prescriptions (27 of 1,067) in 2024. At or below the middle of the specialty; the typical rheumatology clinician is at 3%.

879 generic and 188 brand-name prescriptions · $911,967 in drug cost · 11 antibiotic prescriptions.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Humira18$204,406$11,356
Rinvoq21$127,416$6,067
Xeljanz12$69,542$5,795
Hydroxychloroquine Sulfate123$5,984$49
Leflunomide61$3,558$58
See all 24 drugs
Every Part D drug this clinician prescribed
Humira18$204,406$11,356
Rinvoq21$127,416$6,067
Xeljanz12$69,542$5,795
Hydroxychloroquine Sulfate123$5,984$49
Leflunomide61$3,558$58
Methotrexate72$3,207$45
Mycophenolate Mofetil18$2,206$123
Sulfasalazine Dr35$1,800$51
Colchicine20$1,413$71
Duloxetine32$1,286$40
Diclofenac41$871$21
Prednisone94$785$8
Gabapentin43$723$17
Pregabalin31$578$19
Celecoxib25$487$19
Allopurinol42$388$9
Folic Acid12$291$24
Alendronate26$289$11
Tramadol18$242$13
Meloxicam39$149$4
Cyclobenzaprine12$125$10
Methylprednisolone20$108$5
Leucovorin14$72$5
Alprazolam11$15$1

Year by year

Part D prescribing by year
20241,0672663% (27)18%$911,967
20235711815% (29)12%$201,785
20228062244% (32)None$221,913
20214141175% (21)9%$119,572
20209144NoneNone$29,664
201969140% (0)28%$70,166
201826None0% (0)None$57,577
201713NoneNoneNone$447

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 14 drugs

Part D drugs prescribed in 2023
Hydroxychloroquine Sulfate75$4,143$55
Methotrexate33$2,105$64
Diclofenac58$1,562$27
Sulfasalazine Dr21$1,117$53
Leflunomide18$992$55
Prednisone72$990$14
Gabapentin32$960$30
Colchicine14$928$66
Duloxetine12$652$54
Alendronate15$348$23
Tramadol19$315$17
Allopurinol22$260$12
Celecoxib13$223$17
Meloxicam13$121$9

2022: 17 drugs

Part D drugs prescribed in 2022
Actemra11$37,490$3,408
Hydroxychloroquine Sulfate107$5,720$53
Methotrexate54$3,765$70
Colchicine24$3,603$150
Diclofenac83$2,595$31
Leflunomide16$1,766$110
Sulfasalazine Dr27$1,425$53
Prednisone138$1,201$9
Duloxetine36$1,104$31
Gabapentin52$973$19
Allopurinol45$721$16
Pregabalin14$633$45
Celecoxib11$244$22
Pantoprazole14$181$13
Alendronate14$167$12
Hydrocodone-Acetaminophen16$114$7
Meloxicam13$22$2

2021: 8 drugs

Part D drugs prescribed in 2021
Colchicine27$3,218$119
Diclofenac27$1,914$71
Hydroxychloroquine Sulfate30$1,706$57
Methotrexate31$1,653$53
Prednisone91$977$11
Allopurinol15$152$10
Gabapentin17$117$7
Tramadol11$48$4

2020: 1 drug

Part D drugs prescribed in 2020
Prednisone23$241$10

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
86.1 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1235524596
Licence
CA A143695California A143695: Current · expires 2027-12-31
Trained
University of California, Geffen School of Medicine, 2015
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
Yes
Taxonomy
Federal specialty code 207RR0500X (207RR0500X); Student in a training program (390200000X)
Mailing address
5767 W Century Blvd Ste 400, Los Angeles, CA, 90045
NPI first listed
2015-04-03
NPI last updated
2020-12-15
NPI record certified
2020-12-15

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305